We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

Share Price Information for Pressure Tech (PRES)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 37.50
Bid: 36.00
Ask: 39.00
Change: 0.00 (0.00%)
Spread: 3.00 (8.333%)
Open: 37.50
High: 37.50
Low: 36.00
Prev. Close: 37.50
PRES Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2018 Interim Results

12 Jun 2018 07:00

RNS Number : 0345R
Pressure Technologies PLC
12 June 2018
 

 

 

12 June 2018

 

Pressure Technologies plc

("Pressure Technologies" or the "Group")

 

2018 Interim Results

 

Pressure Technologies (AIM: PRES), the specialist engineering group, announces its interim results for the 26 weeks to 31 March 2018.

 

John Hayward, CEO of Pressure Technologies, said:

"Dynamics in the defence and oil and gas markets are showing considerable momentum, so the outlook for our Manufacturing Divisions is encouraging, but time dependent. There is significant potential in Alternative Energy, and the Board is considering a number of strategic options for this Division that will hopefully increase market opportunities and lead to enhanced shareholder value."

 

Financial

Revenue of £13.6 million (2017: £17.7 million)

Adjusted operating loss* at £(1.3) million (2017: £(0.8) million)

Reported loss before tax of £(5.0) million (2017: £(2.6) million )

Adjusted loss per share of (6.9)p (2017: (6.3)p)

Reported basic loss per share of (25.0)p (2017: (15.9)p)

Adjusted operating cash outflow** £2.1 million (2017: inflow £2.2 million)

Net debt at £9.3 million (2017: £8.6 million )

 

*before M&A costs, amortisation and exceptional charges

**before exceptional cash costs

 

Operational

● The short-term Group outlook is dictated by issues of timing

● Manufacturing Divisions strengthened by the more favourable market conditions in the defence and oil and gas markets

● Delays in contract awards in Alternative Energy negatively impacting the half and full year

● Manufacturing businesses focused on core competency in high added value component manufacture

● Appointment of two highly experienced business leaders to head Alternative Energy and Precision Machined Components Divisions

● Exploring strategic opportunities to unlock value for Shareholders for Alternative Energy

● Post half year end, sale of Hydratron Limited for an initial consideration of £1.1 million

 

For further information, please contact:

 

Pressure Technologies plc

John Hayward, Chief Executive Officer

Joanna Allen, Chief Financial Officer

Keeley Clarke, Investor Relations

 

Today Tel: 020 7920 3150

Thereafter, Tel: 0114 257 3622

www.pressuretechnologies.com

Cantor Fitzgerald Europe (Nominated Adviser and Broker)

Tel: 020 7894 7000

Philip Davies / Will Goode

 

 

Tavistock

Simon Hudson

 

Tel: 020 7920 3150

COMPANY DESCRIPTION

 

Company description - www.pressuretechnologies.com

With its head office in Sheffield, Pressure Technologies was founded on its leading market position as a designer and manufacturer of high-pressure components and systems serving the global energy, defence and industrial gases markets. Today it continues to serve those markets from a broader engineering base with specialist precision engineering businesses and has a worldwide presence in Alternative Energy as a global leader in biogas upgrading.

Pressure Technologies has three divisions, Precision Machined Components, Cylinders and Alternative Energy, serving four main markets: oil and gas, defence, industrial gases and alternative energy.

Precision Machined Components - www.pt-pmc.com

● Al-Met, Mid Glamorgan, acquired in 2010 www.almet.co.uk 

● Roota Engineering, Rotherham, acquired in March 2014 www.roota.co.uk 

● Quadscot, Glasgow, acquired in October 2014 www.quadscot.co.uk 

● Martract Limited, Barton-on-Humber, acquired in December 2016 www.martract.co.uk 

 

Cylinders

● Chesterfield Special Cylinders, Sheffield, IPO cornerstone in 2007 and includes, CSC Deutschland Gmbh, which is based in Dorsten, Germany and Chesterfield Special Cylinders Inc. which is based in Houston, USA www.chesterfieldcylinders.com 

 

Alternative Energy

● Greenlane Biogas, Vancouver, Canada and Sheffield, UK; acquired in October 2014 www.greenlanebiogas.com 

 

 

 

Chairman and Chief Executive's statement

 

Group revenues for the 26 weeks to 31 March 2018 were down £4.1 million to £13.6 million (2017: £17.7 million) primarily due to a lower opening order book in the Alternative Energy Division (AE) (2018: £5.0 million, 2017: £14.0 million) compounded by low order intake in the period. More encouragingly, revenues in our manufacturing Divisions increased by 10% like-for-like during the first-half.

 

As a consequence of reduced revenues, the Group made an adjusted operating loss* of £1.3 million (2017: loss £0.8 million).

 

First-half trading reflects solid defence business in our Cylinders Division ("CSC"), growing confidence in the oil and gas market which positively impacted the Precision Machined Components Division ("PMC") and delays caused by the still nascent market for renewables for the Alternative Energy Division ("AE").

 

On 7 June 2018, Hydratron Limited, which comprises the Group's Engineered Products Division ("EP"), was sold to Pryme Group Limited for an initial cash consideration of £1.1 million. Additional consideration of up to £2.25 million may become payable depending upon Hydratron's trading performance for the twelve month period to 31 May 2019. 

 

 

Balance Sheet

 

Net Assets increased to £34.5 million (2017: £32.7 million). The balance sheet was strengthened by the £4.8 million net fundraising in November 2017, £2.7 million of which was used to pay-down a tranche of the Group's revolving credit facility. As anticipated, with the building momentum in PMC and phasing of large projects in CSC and AE, there was a net investment in working capital in the period totalling £1.5 million. This, combined with the operating losses, resulted in a net adjusted cash outflow** in the period of £2.1 million (2017: inflow £2.2 million). Net Debt closed at £9.3 million, down from £11.1 million at the year-end.

 

The post-balance sheet disposal of Hydratron gave rise to an impairment of goodwill of £1.7 million. The disposal crystallised a fair market value assessment and the Board considered it appropriate to recognise the impairment in the results for the first-half of the current financial year. The proceeds of the disposal have been used to further reduce the Group's debt and the Group is currently £11.8 million drawn on the £15.0 million revolving credit facility. The Group's bankers have committed to further extend the facility repayment date to 31 January 2020.

 

People

 

During the period, we recruited two highly experienced business leaders to head our AE and PMC Divisions.

 

In February 2018, we conducted a Group-wide Staff Engagement survey to assess how employees feel about a range of factors associated with working within the Group. Results were very encouraging, as they revealed a high degree of engagement within the Group, with staff reporting a real sense of pride in the companies they work for, a high degree of team spirit and that their skills are being effectively utilised. This is a strong platform to build upon as we continue to grow and develop the business.

 

The Manufacturing Divisions

 

 

 

2018 H1

2017 H2

2017 H1

2017 FY

Revenue

£10.8m

£12.9m

£9.7m

£22.6m

Operating Profit*

£0.5m

£2.4m

£0.0m

£2.4m

 

A more favourable oil and gas market and a strong defence order book have lifted sales and profits for these Divisions during the period. With increased volumes at PMC, reduced losses at the now divested EP Division and increased defence revenue at CSC.

 

Precision Machined Components Division

 

 

2018 H1

2017 H2

2017 H1

2017 FY

Revenue

£5.5m

£5.7m

£5.0m

£10.7m

Operating Profit*

£0.6m

£0.9m

£0.9m

£1.8m

 

The Division offers four highly specialist engineering businesses under the PMC brand: Al-Met, Roota Engineering, Quadscot Precision Engineers and Martract, all focused on high quality, low volume and high added value components. The strategy for the Division is to expand the existing business initially through increased collaboration, cross-selling, product and key account expansion as well as the development of new markets that are in line with our core competences.

 

Revenues benefitted from more favourable oil and gas market conditions, although margins in the first-half were affected by a combination of product mix and ongoing investment in people and equipment as we align the Division for growth. In time margins should improve due to a combination of increased volumes of higher margin subsea components and the effects of operational gearing arising from a general rise in volumes.

 

The oil and gas market environment has realigned itself during the downturn, whereby customers have introduced automotive sector type disciplines with a reduced list of preferred suppliers capable of responding to demanding, shorter lead times. Key drivers for success in this environment are quality, cost and delivery, all of which play to our strengths. It is therefore pleasing to report that we have appointed a Divisional Managing Director, Martin Wood. Martin brings significant experience of the automotive component sector, as well as relevant experience in the oil and gas market.

 

Whilst the oil and gas market is improving, PMC continues to experience some variability in the order intake. For the last three half-years, PMC has consistently seen order intake rising. At the half-year, the closing order book was 29% higher than the comparative period and order intake for the period 33% higher.

 

Order intake at the start of the third-quarter has been a little muted, but requests for quotations have accelerated, particularly at Quadscot, and are at the highest level since the start of the market downturn in late 2014. The recent slowing of order intake makes us slightly more cautious about the Division's full-year outlook but with short order to delivery lead-times now the market norm, this can change within a quarter.

 

 

Cylinders Division

 

 

2018 H1

2017 H2

2017 H1

2017 FY

Revenue

£3.9m

£5.3m

£3.1m

£8.4m

Operating Profit*

£0.0m

£1.6m

£(0.6)m

£1.0m

 

CSC supplies a range of high-pressure gas cylinder systems into the defence, oil and gas and industrial gases markets. The defence market is currently the key focus for CSC, with order book visibility to 2021, underpinned by the supply of cylinders for the first Dreadnought submarine (Trident replacement) during 2018 and 2019. The Division has over 80 years of experience in providing cylinders and services to the naval and military aerospace markets. This heritage in a highly demanding market, makes CSC the natural choice for cutting edge product development.

 

First-half results were underpinned by an increase in defence contracts. Manufacturing of standard design naval cylinders has commenced for the Dreadnought project, but we await the order to start manufacture of the programme specific cylinders. As reported in the recent trading update, timing of this will move revenue and profit between financial years, with any shortfall in 2018 recovered in 2019. Encouragingly, a number of other UK and overseas defence projects have been won, including an order for cylinders for the MoD's Type 26 Frigate programme for supply from 2019.

 

Whilst the oil and gas market has reduced in importance for the Division, it is pleasing to note that two orders for the supply of air pressure vessels for drillship projects have been secured; the only two new projects placed globally in the last three years. This demonstrates the Division's reputation and continuing cost competitiveness in this market.

 

Revenues derived from our service offerings, including Integrity Management ("IM"), were relatively flat year on year (2018: £1.3 million, 2017: £1.4 million) due to a final oxygen cylinder cleaning order in 2017 for the Astute submarine programme and delays in the award of the next MoD naval support contract in 2018. The IM team has a strong presence in the UK defence market and further short-term opportunities exist in Europe, where they were recently awarded their first overseas defence project.

 

Medium-term growth for this Division will come from further global defence opportunities. Beyond that, the Board believes opportunities exist in the hydrogen market, where the Division recently won a first order to supply hydrogen storage cylinders.

 

The Division is in a robust position with good visibility of future defence contracts, together with opportunities from the recovering oil and gas market and immediate and growing prospects in renewable fuels.

 

Engineered Products

 

 

2018 H1

2017 H2

2017 H1

2017 FY

Revenue

£1.7m

£2.2m

£1.7m

£3.9m

Operating Loss*

£(0.2)m

£(0.2)m

£(0.3)m

£(0.5)m

 

The Division manufactures a range of Hydratron-branded air-operated, high-pressure hydraulic pumps, gas boosters, power packs, hydraulic control panels and test rigs, mainly for use in the oil and gas sector.

 

The first-half of the financial year saw a continuation of the gradual improving performance that started in 2017, with a more profitable mix of projects, but unpredictable order intake patterns.

 

The prolonged downturn in the oil and gas market has impacted Hydratron more so than the Group's Precision Machined Components Division. Successful steps had been taken to re-align the business with its core markets and establish the foundations for future growth. However, the Board concluded that Hydratron would be better served as part of a group that can enhance its critical mass and market position and it was sold to Pryme Group Limited on 7 June 2018.

 

Alternative Energy

 

 

2018 H1

2017 H2

2017 H1

2017 FY

Revenue

£2.8m

£7.8m

£8.0m

£15.8m

Operating Profit*

£(0.8)m

£(0.1)m

£0.1m

£0.0m

 

AE is a designer and supplier of equipment used to upgrade biogas produced by the anaerobic digestion of organic waste, to high-quality methane suitable for either injection into the natural gas grid or direct use as vehicle fuel. The Division trades under the brand name of Greenlane Biogas, the long-established market leader in water-wash biogas upgrader equipment. 

 

The Division started the year with an order book of £5.0 million (2017: £14. 0 million). During the first-half, three new upgrader contracts were awarded. Additional projects were anticipated but delayed for reasons outside the control of the Division. In North and South America, delays arose from a combination of environmental permitting, complexity of contracts and clients' funding arrangements. In the UK, the major reason for delays has been extremely slow progress of the Renewable Heat Incentive (RHI) legislation through Parliament. It is pleasing to note that this was finally approved on 22 May 2018, some four months later than the energy market had anticipated.

 

Profit recognition on our upgrading projects is necessarily skewed towards completion, so delays in contract awards experienced to date will negatively impact our full-year results and the Division will be loss making for the year.

 

As detailed in our 2017 annual report the Division undertook a major reorganisation. As a result, the Division is now centred in Vancouver, Canada, close to the US market where we see the greatest opportunity for biogas upgrading projects, while retaining presence in the important European market with staff in the UK, France, Sweden and Germany. In November 2017, as part of the restructuring, we appointed a Divisional President, Brad Douville, with experience of growing a renewable energy business and he has brought renewed focus to realising the potential of the business.

 

During the period, the Division scored a number of notable successes which demonstrate its continued leadership in the biogas upgrading market, such as; meeting of the world's tightest gas grid standards in California and the introduction of the world's largest single upgrader currently undergoing commissioning in Arizona. Further progress has been made in establishing commercial partnerships to expand project opportunities worldwide. Strategic relationships have been formed, one of which will give access to Pressure Swing Adsorption (PSA) technology, thereby expanding our product portfolio and broadening our market access.

The biogas market offers substantial potential, particularly in North America and Europe, backed by a range of government targets, incentives and subsidies. However, the market has been frustratingly slow to deliver, prompting a review of strategic options for the Division to unlock better value for shareholders.

 

Outlook

 

As outlined in our recent trading update, first-half financial performance has been somewhat subdued due to customers delaying placement of new orders; a market dynamic that we've seen in all Divisions. However, the underlying strength of our Divisions is robust and our capability to execute projects effectively and profitably remains sound.

 

With the disposal of EP, our remaining Manufacturing Divisions, Cylinders and PMC, will continue to focus on our core competence: supplying low volume, high added value, safety critical, complex components, where the cost of a component is orders of magnitude smaller than the opportunity cost of failure.

 

Dynamics in the defence and oil and gas markets are showing considerable momentum, so the outlook for CSC and PMC is encouraging, but time dependent. There is significant potential in AE, and the Board is considering a number of strategic options for this Division that will hopefully increase market opportunities and lead to enhanced shareholder value.

 

Alan Wilson

Chairman

 

12 June 2018

John Hayward

Chief Executive

 

*before M&A costs, amortisation and exceptional charges

**before exceptional cash costs

 

 

Condensed Consolidated Statement of Comprehensive Income

For the 26 weeks ended 31 March 2018

 

Unaudited

26 weeks

ended

31 March 2018

Unaudited

26 weeks

ended

1 April

2017

Audited

52 weeks

ended

30 September 2017

 

Notes

£'000

£'000

£'000

 

 

Revenue

2

13,631

17,733

38,418

 

Cost of sales

(9,424)

(13,509)

(27,710)

 

 

Gross profit

4,207

4,224

10,708

 

 

Administration expenses

(5,466)

(4,985)

(9,611)

 

 

Operating (loss)/profit before M&A costs, amortisation and exceptional charges

(1,259)

(761)

1,097

Separately disclosed items of administrative expenses:

Amortisation and M&A related exceptional items

 

3

(2,978)

(1,285)

(1,968)

Other exceptional charges

4

(558)

(421)

(703)

Operating loss

(4,795)

(2,467)

(1,574)

Finance income

-

-

4

Finance costs

(182)

(124)

(343)

 

 

Loss before taxation

(4,977)

(2,591)

(1,913)

 

 

Taxation

5

533

284

766

 

 

Loss for the period attributable to owners of the parent

(4,444)

(2,307)

(1,147)

 

 

Other comprehensive income:

Items that may be reclassified subsequently to profit or loss:

Currency transaction differences on translation of foreign operations

10

-

(4)

Total comprehensive income for the period attributable to the owners of the parent

(4,434)

(2,307)

(1,151)

 

 

 

Loss per share from continuing operations

 

Loss per share basic

6

(25.0)p

(15.9)p

(7.9)p

 

Loss per share diluted

6

(25.0)p

(15.9)p

(7.9)p

 

 

Condensed Consolidated Balance Sheet

As at 31 March 2018

 

Unaudited

26 weeks

ended

31 March 2018

Unaudited

26 weeks

ended

1 April

2017

Audited

52 weeks

ended

30 September 2017

Notes

£'000

£'000

£'000

Non-current assets

Goodwill

14,370

16,062

16,062

Intangible assets

12,652

13,913

13,658

Property, plant and equipment

12,233

13,249

12,583

Deferred tax asset

343

502

343

39,598

43,726

42,646

Current assets

Inventories

5,972

5,245

4,986

Trade and other receivables

10,042

8,818

11,339

Cash and cash equivalents

7

3,883

7,415

4,791

Current tax asset

421

-

-

20,318

21,478

21,116

Total assets

59,916

65,204

63,762

Current liabilities

Trade and other payables

(10,042)

(12,854)

(11,748)

Deferred consideration

-

(589)

-

Borrowings

7

(220)

(210)

(219)

Current tax liabilities

-

(340)

(23)

(10,262)

(13,993)

(11,990)

Non-current liabilities

Other payables

(218)

(281)

(238)

Borrowings

7

(13,009)

(15,756)

(15,642)

Deferred tax liabilities

(1,944)

(2,496)

(2,089)

(15,171)

(18,533)

(17,969)

Total liabilities

(25,433)

(32,526)

(29,959)

Net assets

34,483

32,678

33,803

Share capital

931

725

725

Share premium account

26,451

21,637

21,637

Translation reserve

(395)

(401)

(405)

Retained earnings

7,496

10,717

11,846

Total equity

34,483

32,678

33,803

 

 

Condensed Consolidated Statement of Changes in Equity

For the 26 weeks ended 31 March 2018

Share

capital

Share

premium

account

Translation reserve

Profit and

loss

account

Total

equity

£'000

£'000

£'000

£'000

£'000

Balance at 30 September 2017 (audited)

725

21,637

(405)

11,846

33,803

Share based payments

-

-

-

94

94

Shares issued

206

4,814

-

-

5,020

Transactions with owners

206

4,814

-

94

5,114

Loss for the period

-

-

-

(4,444)

(4,444)

Exchange differences arising on retranslation of foreign operations

-

-

10

-

10

Total comprehensive income

-

-

10

(4,444)

(4,434)

Balance at 31 March 2018 (unaudited)

931

26,451

(395)

7,496

34,483

 

 

For the 26 weeks ended 1 April 2017

 

Share

capital

Share

premium

account

Translation reserve

Profit and

loss

account

Total

equity

£'000

£'000

£'000

£'000

£'000

Balance at 1 October 2016 (audited)

724

21,620

(401)

12,872

34,815

Share based payments

-

-

-

152

152

Shares issued

1

17

-

-

18

Transactions with owners

1

17

-

152

170

Loss for the period

-

-

-

(2,307)

(2,307)

Exchange differences arising on retranslation of foreign operations

-

-

-

-

-

Total comprehensive income

-

-

-

(2,307)

(2,307)

Balance at 1 April 2017 (unaudited)

725

21,637

(401)

10,717

32,678

 

Condensed Consolidated Statement of Changes in Equity (continued)

For the 52 weeks ended 30 September 2017

 

Share

capital

Share

premium

account

Translation reserve

 

Profit and loss account

Total

Equity

£'000

£'000

£'000

£'000

£'000

Balance at 1 October 2016 (audited)

724

21,620

(401)

12,872

34,815

Share based payments

-

-

-

121

121

Shares issued

1

17

-

-

18

Transactions with owners

1

17

-

121

139

Loss for the period

-

-

-

(1,147)

(1,147)

Other comprehensive income:

Exchange differences on translating foreign operations

-

-

(4)

 

 

-

(4)

Total comprehensive income

-

-

(4)

(1,147)

(1,151)

Balance at 30 September 2017 (audited)

725

21,637

(405)

 

11,846

33,803

 

 

Condensed Consolidated Cash Flow Statement

For the 26 weeks ended 31 March 2018

 

Unaudited

26 weeks

ended

31 March 2018

Unaudited

26 weeks

ended

1 April

2017

Audited

52 weeks

ended

30 September 2017

£'000

£'000

£'000

Cash flows from operating activities

Loss after tax

(4,444)

(2,307)

(1,147)

Adjustments for:

Depreciation of property, plant and equipment

697

683

1,438

Finance costs - net

182

124

339

Amortisation of intangible assets

1,286

1,202

2,407

Loss on disposal of property, plant and equipment

2

-

21

Share option costs

94

152

121

Income tax credit

(533)

(284)

(766)

Exceptional goodwill impairment

1,692

-

-

Exceptional deferred consideration released and revaluation

-

-

(597)

Exceptional impairment of assets

-

-

11

Changes in working capital:

(Increase)/decrease in inventories

(986)

(16)

243

Decrease in trade and other receivables

1,297

2,617

413

Decrease in trade and other payables

(1,802)

(427)

(2,164)

Cash flows from operating activities

(2,515)

1,744

319

Finance costs paid

(100)

(124)

(324)

Income tax (paid)/ refunded

(56)

185

216

_______

Net cash from operating activities

(2,671)

1,805

211

Cash flows from investing activities

Purchase of property, plant and equipment

(441)

(88)

(961)

Proceeds from sale of fixed assets

26

-

21

Cash outflow on purchase of subsidiaries net of cash acquired

(3,597)

(3,597)

Net cash used in investing activities

(415)

(3,685)

(4,537)

Financing activities

New borrowings

-

3,350

3,350

Repayment of borrowings

(2,842)

(145)

(324)

Shares issued

5,020

17

18

______

______

______

Net cash used for financing activities

2,178

3,222

3,044

Net (decrease)/increase in cash and cash equivalents

(908)

1,342

(1,282)

Cash and cash equivalents at beginning of period

4,791

6,073

6,073

Cash and cash equivalents at end of period

3,883

7,415

4,791

 

 

Notes to the Condensed Consolidated Interim Financial Statements

 

1. Basis of preparation

 

The Group's interim results for the 26 weeks ended 31 March 2018 are prepared in accordance with the Group's accounting policies which are based on the recognition and measurement principles of International Financial Reporting Standards ("IFRS") as adopted by the EU and effective, or expected to be adopted and effective, at 29 September 2018. As permitted, this interim report has been prepared in accordance with the AIM rules and not in accordance with IAS34 "Interim financial reporting" and therefore the interim information is not in full compliance with IFRS. The principal accounting policies of the Group have remained unchanged from those set out in the Group's 2017 annual report and financial statements.

 

The Group's 2017 financial statements for the 52 weeks ended 30 September 2017 were prepared under IFRS. The auditor's report on these financial statements was unmodified and did not contain statements under Sections 498(2) or (3) of the Companies Act 2006 and they have been filed with the Registrar of Companies.

 

The consolidated financial statements are prepared under the historical cost convention as modified to include the revaluation of financial instruments.

 

The financial information for the 26 weeks ended 31 March 2018 and 1 April 2017 has not been audited or reviewed and does not constitute full financial statements within the meaning of Section 434 of the Companies Act 2006. The unaudited interim financial statements were approved by the Board of Directors on 12 June 2018.

 

2. Segmental analysis

 

Revenue by destination

 

Unaudited

26 weeks

ended

31 March 2018

Unaudited

26 weeks

ended

1 April

2017

Audited

52 weeks

ended

30 September 2017

£'000

£'000

£'000

United Kingdom

5,447

6,785

15,451

Other EU

3,953

2,674

7,050

Rest of World

4,231

8,274

15,917

13,631

17,733

38,418

 

Revenue by sector

 

Unaudited

26 weeks

ended

31 March 2018

Unaudited

26 weeks

ended

1 April

2017

Audited

52 weeks

ended

30 September 2017

£'000

£'000

£'000

Oil and gas

7,097

6,774

13,775

Defence

2,520

1,909

6,471

Industrial gases

1,201

1,017

2,347

Alternative energy

2,813

8,033

15,825

13,631

17,733

38,418

 

 

2. Segmental analysis (continued)

 

Revenue by activity

 

Unaudited

26 weeks

ended

31 March

2018

Unaudited

26 weeks

ended

1 April

2017

Audited

52 weeks

ended

30 September 2017

£'000

£'000

£'000

Cylinders

3,855

3,108

8,403

Precision Machined Components

5,512

5,014

10,703

Engineered Products

1,698

1,731

3,861

Intra divisional

(229)

(136)

(349)

_______

_______

_______

Manufacturing subtotal

10,836

9,717

22,618

Alternative Energy

2,795

8,016

15,800

13,631

17,733

38,418

Profit/(loss) from continuing operations before taxation by activity

Unaudited

26 weeks

ended

31 March

2018

Unaudited

26 weeks

ended

1 April

2017

Audited

52 weeks

ended

30 September 2017

£'000

£'000

£'000

Cylinders

14

(627)

1,062

Precision Machined Components

625

866

1,840

Engineered Products

(150)

(284)

(471)

_______

_______

_______

Manufacturing subtotal

489

(45)

2,431

Alternative Energy

(807)

91

3

Unallocated central costs

(941)

(807)

(1,337)

_______

_______

_______

Operating (loss)/profit pre amortisation and M&A related exceptional items

(1,259)

(761)

1,097

Amortisation and M&A related exceptional items

(2,978)

(1,285)

(1,968)

Other exceptional charges

(558)

(421)

(703)

_______

Operating loss

(4,795)

(2,467)

(1,574)

Finance costs

(182)

(124)

(339)

_______

_______

_______

Loss before tax

(4,977)

(2,591)

(1,913)

______

_______

_______

 

 

The Operating (loss)/profit before taxation by activity is stated before the allocation of Group management charges.

 

 

2. Segmental analysis (continued)

 

Earnings before interest, taxation, depreciation, and amortisation (EBITDA)

 

Unaudited

26 weeks

ended

31 March

2018

Unaudited

26 weeks

ended

1 April

2017

Audited

52 weeks

ended

30 September 2017

£'000

£'000

£'000

Adjusted EBITDA

(562)

(78)

2,535

M&A costs and related exceptional items

(1,692)

(83)

439

Other exceptional charges

(558)

(421)

(703)

EBITDA

(2,812)

(582)

2,271

Depreciation

(697)

(683)

(1,438)

Amortisation re: acquired businesses

(1,286)

(1,202)

(2,407)

Interest

(182)

(124)

(339)

Loss before tax

(4,977)

(2,591)

(1,913)

 

Amortisation on acquired businesses as set out above consists of the amortisation charged on intangible assets acquired as a result of business combinations in previous periods.

 

3. Amortisation and M&A related exceptional items

 

M&A related exceptional items and amortisation of intangible assets are shown separately in the Condensed Consolidated Statement of Comprehensive Income. A breakdown of those costs can be seen below.

 

Unaudited

26 weeks

ended

31 March

2018

Unaudited

26 weeks

ended

1 April

2017

Audited

52 weeks

ended

30 September 2017

£'000

£'000

£'000

Amortisation of intangible assets arising on a business combination

(1,286)

(1,202)

(2,407)

Goodwill impairment

(1,692)

-

-

M&A costs

-

(83)

(158)

Deferred consideration write back

-

-

597

(2,978)

(1,285)

(1,968)

 

 

The Goodwill impairment relates to a full write down of the goodwill which arose on the acquisition of Hydratron Limited. The disposal of Hydratron Limited (note 10) provided an indicator of impairment, with the divestment crystallising a fair market value assessment and the Directors considered it appropriate to recognise the impairment in the 6 month period ended 31 March 2018.

 

The deferred consideration write back for the period ended 30 September 2017 related to the deferred consideration arising

from the acquisition of Martract Limited. The payment of this consideration was contingent on the future results of Martract. Given the magnitude of the amount released and the fact that it was non-trading, the Directors considered it appropriate to disclose it as an exceptional item.

 

 

4. Other exceptional charges

 

Items that are material either because of their size or their nature, or that are non-recurring are considered as exceptional items and are disclosed separately on the face of the Condensed Consolidated Statement of Comprehensive Income.

 

An analysis of the amounts presented as exceptional items in these financial statements is given below:

 

Unaudited

26 weeks

ended

31 March

2018

Unaudited

26 weeks

ended

1 April

2017

Audited

52 weeks

ended

30 September 2017

£'000

£'000

£'000

Reorganisation and redundancy

(290)

(401)

(710)

Costs in relation to HSE investigation

(6)

(20)

(21)

Share placing costs

(262)

-

-

Write back of KGTM loan previously provided for

-

-

28

(558)

(421)

(703)

 

The reorganisation costs relate to costs of restructuring across the Group. They are recognised in accordance with IAS 19.

 

Costs in relation to the HSE investigation are costs borne by the Group as a direct result of the accident at Chesterfield Special Cylinders which are not recoverable through insurance.

 

The write back of KGTM loan previously provided for, related to a receipt from KGTM for a loan amount that was previously provided for (reversal of the provision).

The share placing costs are transaction costs relating to the share issue on 6 November 2017.

 

Given the non-trading nature of these costs, the Directors consider it appropriate to disclose these as exceptional items.

 

5. Taxation

 

Unaudited

26 weeks

ended

31 March

2018

Unaudited

26 weeks

ended

1 April

2017

Audited

52 weeks

ended

30 September 2017

£'000

£'000

£'000

Current tax credit

386

125

356

Deferred taxation credit

147

159

410

Taxation credit to the income statement

533

284

766

 

The tax charge differs from the theoretical amount that would arise using the weighted average tax rate applicable to the profits of the consolidated entities.

 

 

6. Earnings/(loss) per ordinary share

 

The calculation of basic earnings per share is based on the earnings attributable to ordinary shareholders divided by the weighted average number of shares in issue during the period.

 

The calculation of diluted earnings per share is based on basic earnings per share, adjusted to allow for the issue of shares on the assumed conversion of all dilutive options.

 

Adjusted earnings per share shows earnings per share, adjusting for the impact of M&A costs, the amortisation charged on intangible assets acquired as a result of business combinations, any exceptional items, and for the estimated tax impact, if any, of those costs. Adjusted earnings per share is based on the profits as adjusted divided by the weighted average number of shares in issue.

 

 

Unaudited

26 weeks

ended

31 March

2018

Unaudited

26 weeks

ended

1 April

2017

Audited

52 weeks

ended

30 September 2017

£'000

£'000

£'000

Loss after tax for basic and diluted earnings per share

(4,444)

(2,307)

(1,147)

(Loss)/profit after tax for adjusted earnings per share:

Loss after tax as above

(4,444)

(2,307)

(1,147)

Amortisation and M&A related exceptional items

2,978

1,285

1,968

Other exceptional charges

558

421

703

Tax movement thereon

(325)

(317)

(606)

(Loss)/profit after tax for adjusted earnings per share

(1,233)

(918)

918

 

 

 

 

 

 

 

 

 

Number of

Shares

Number of

Shares

Number of shares

Weighted average number of shares in issue

17,779,695

14,474,848

14,485,099

Dilutive effect of options

-

3,766

75

Diluted weighted average number of shares

17,779,695

14,478,614

14,485,174

Loss per share - basic

(25.0)p

(15.9)p

(7.9)p

Loss per share - diluted

(25.0)p

(15.9)p

(7.9)p

Adjusted (loss)/earnings per share - basic

(6.9)p

(6.3)p

6.3p

 

In the current period the Group has recorded a loss after tax and therefore the options are antidilutive.

7. Reconciliation of net borrowings

 

Unaudited

26 weeks

ended

31 March

2018

Unaudited

26 weeks

ended

1 April

2017

Audited

52 weeks

ended

30 September 2017

£'000

£'000

£'000

Cash and cash equivalents

3,883

7,415

4,791

Bank borrowings

(12,300)

(15,000)

(15,000)

Finance leases

(929)

(966)

(861)

Net borrowings

(9,346)

(8,551)

(11,070)

 

At the balance sheet date, the above bank borrowings were due for repayment on 31 March 2019, being exactly 12 months from the balance sheet date. On 11 June the bank committed to extend the repayment date to 31 January 2020. Accordingly the directors have concluded that it is appropriate to present the loan as due for repayment after one year.

 

 

8. Contingent liabilities

Following the fatal accident at Chesterfield Special Cylinders ("CSC") in June 2015, other than the submission by CSC of written responses to questions from the Health and Safety Executive ("HSE"), there have been no further developments since the preliminary statement on 12 December 2017 and the HSE investigation into this accident remains ongoing. On 1 February 2016 the Sentencing Council's new "Health and Safety Offences, Corporate Manslaughter and Food Safety and Hygiene Offences Definitive Guideline" (2016) came into force.

The guidelines set a range of fines dependent on the levels of harm and culpability. These levels are assessed by the Judge when sentencing and not at the time of charges being brought. We continue to cooperate fully with the HSE. Until the HSE investigation is complete CSC's management and legal adviser are not in a position to assess what charges may be brought. As a result of this and the nature of the sentencing guidelines it is not possible to determine with any degree of certainty what, if any, financial penalties may be levied on CSC or any other group company as a result of this investigation. At such time as the quantum and likelihood of any penalty is able to be reliably determined further disclosure or provision will be made in accordance with IAS 37 "Provisions, Contingent Liabilities and Contingent Assets".

 

9. Dividends

 

No final or interim dividend was paid for 52 week periods ended 1 October 2016 or 30 September 2017. No interim dividend for the 52 week period ending 29 September 2018 is proposed.

 

A copy of the Interim Report will be sent to shareholders shortly and will be available on the Company's website: www.pressuretechnologies.com.

 

 

10. Post Balance Sheet event

 

On 7 June 2018, and as separately communicated to Shareholders on that date, the Group completed the disposal ofthe entire issued share capital of its subsidiary, Hydratron Limited, to Pryme Group Limited, majority owned by Simmons Private Equity LP. This business is reported by the Group as the Engineered Products segment.

The initial consideration is £1.1m (less costs and retentions), along with potential deferred contingent consideration up to a maximum of £2.3m, dependent on revenue in the twelve months post completion. As detailed in Note 3 to these financial statements a goodwill impairment of £1.7m was recognised as an exceptional charge in the 6 month period ended 31 March 2018.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR FBMFTMBABBRP
Date   Source Headline
21st Mar 202412:10 pmRNSResults of 2024 Annual General Meeting
14th Mar 20247:00 amRNSContract Placements and Update on Sale of PMC
14th Feb 20247:00 amRNSNotice of 2024 Annual General Meeting
30th Jan 20247:00 amRNS2023 Full-Year Results
16th Nov 20237:00 amRNSDebt Refinancing and Grant of Warrants
24th Oct 20237:00 amRNSDebt Refinancing - Agreement in Principle
9th Oct 20239:28 amRNSHolding(s) in Company
5th Oct 20233:56 pmRNSHolding(s) in Company
5th Oct 20233:52 pmRNSHolding(s) in Company
5th Oct 20232:38 pmRNSHolding(s) in Company
4th Oct 20233:10 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSPost-Close Update
11th Aug 20232:24 pmRNSHolding(s) in Company
27th Jun 20237:00 amRNS2023 Interim Results
13th Jun 202311:40 amRNSResult of General Meeting
26th May 202312:02 pmRNSHolding(s) in Company
23rd May 20237:30 amRNSRestoration - Pressure Technologies plc
23rd May 20237:05 amRNSConfirmation of Board Appointments
23rd May 20237:00 amRNS2022 Full-Year Results
27th Apr 202310:30 amRNSFurther Update on FY22 Annual Report & Accounts
3rd Apr 20237:30 amRNSSuspension - Pressure Technologies plc
31st Mar 20231:56 pmRNSResult of AGM
27th Mar 20237:05 amRNSMajor Order Placement
27th Mar 20237:00 amRNSUpdate on Annual Report and Accounts
21st Mar 20237:05 amRNSBoard Appointments
21st Mar 20237:00 amRNSUpdate on FY22 Audit, AGM & Current Trading
7th Mar 20237:00 amRNSNotice of AGM
6th Feb 20237:00 amRNSContract
17th Jan 20237:00 amRNSAppointment of Chief Financial Officer
21st Dec 202211:57 amRNSHolding(s) in Company
8th Dec 20227:58 amRNSHolding(s) in Company
7th Dec 20221:44 pmRNSHolding(s) in Company
2nd Dec 20221:20 pmRNSResult of General Meeting
15th Nov 20223:18 pmRNSRESULT OF PLACING AND RETAIL OFFER
15th Nov 20227:01 amRNSREX Retail Offer
15th Nov 20227:00 amRNSPROPOSED PLACING AND RETAIL OFFER
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 202210:37 amRNSHolding(s) in Company
3rd Oct 202212:38 pmRNSHolding(s) in Company
30th Sep 20224:47 pmRNSHolding(s) in Company
29th Sep 20225:31 pmRNSHolding(s) in Company
29th Sep 20222:05 pmRNSSecond Price Monitoring Extn
29th Sep 20222:00 pmRNSPrice Monitoring Extension
28th Sep 20225:02 pmRNSHolding(s) in Company
28th Sep 20224:41 pmRNSSecond Price Monitoring Extn
28th Sep 20224:35 pmRNSPrice Monitoring Extension
27th Sep 20224:40 pmRNSSecond Price Monitoring Extn
27th Sep 20224:35 pmRNSPrice Monitoring Extension
27th Sep 20222:06 pmRNSSecond Price Monitoring Extn
27th Sep 20222:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.